GeneDx (NASDAQ:WGSWW – Get Free Report) is anticipated to release its resultson Monday, May 4th. Analysts expect GeneDx to post earnings of ($0.0150) per share and revenue of $112.4560 million for the quarter.
GeneDx Stock Performance
WGSWW opened at $0.01 on Friday. The company’s 50 day moving average is $0.01 and its 200-day moving average is $0.04. GeneDx has a 1-year low of $0.00 and a 1-year high of $0.14.
About GeneDx
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.
See Also
Receive News & Ratings for GeneDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneDx and related companies with MarketBeat.com's FREE daily email newsletter.
